Key result
Total blood omega-3 fatty acid levels were not associated with nonparoxysmal versus paroxysmal atrial fibrillation in multivariate analysis.
Why the study?
Previous randomized controlled trials showed mixed results concerning the effect of omega-3 fatty acids on AF, and the associations of n-3 FA blood levels with heart rhythm, heart rate, and heart rate variability in patients with established AF were unknown.
Are whole blood levels of total and individual omega-3 fatty acids associated with atrial fibrillation type (nonparoxysmal vs paroxysmal), heart rate, and heart rate variability in patients with established atrial fibrillation?
Cross-Sectional (n=1,969)
Yes
Are whole blood levels of total and individual omega-3 fatty acids associated with atrial fibrillation type (nonparoxysmal vs paroxysmal), heart rate, and heart rate variability in patients with established atrial fibrillation?
Answers are grounded in this paper and cite their sources.
In patients with established atrial fibrillation, whole blood omega-3 fatty acid levels are not associated with AF type (paroxysmal vs nonparoxysmal), though higher total n-3 FAs and DHA correlate slightly with lower resting heart rate and higher DPA correlates with lower heart rate variability.
Background Previous randomized control trials showed mixed results concerning the effect of omega-3 fatty acids (n-3 FAs) on atrial fibrillation (AF). The associations of n-3 FA blood levels with heart rhythm in patients with established AF are unknown. The goal of this study was to assess the associations of total and individual n-3 FA blood levels with AF type (paroxysmal versus nonparoxysmal), heart rate (HR), and HR variability in patients with AF. Methods and Results Total n-3 FAs, eicosapentaenoic acid, docosahexaenoic acid, docosapentaenoic acid, and alpha-linolenic acid blood levels were determined in 1969 patients with known AF from the SWISS-AF (Swiss Atrial Fibrillation cohort). Individual and total n-3 FAs were correlated with type of AF, HR, and HR variability using standard logistic and linear regression, adjusted for potential confounders. Only a mild association with nonparoxysmal AF was found with total n-3 FA (odds ratio [OR], 0.97 [95% CI, 0.89-1.05]) and docosahexaenoic acid (OR, 0.93 [95% CI, 0.82-1.06]), whereas other individual n-3 FAs showed no association with nonparoxysmal AF. Higher total n-3 FAs (estimate 0.99 [95% CI, 0.98-1.00]) and higher docosahexaenoic acid (0.99 [95% CI, 0.97-1.00]) tended to be associated with slower HR in multivariate analysis. Docosapentaenoic acid was associated with a lower HR variability triangular index (0.94 [95% CI, 0.89-0.99]). Conclusions We found no strong evidence for an association of n-3 FA blood levels with AF type, but higher total n-3 FA levels and docosahexaenoic acid might correlate with lower HR, and docosapentaenoic acid with a lower HR variability triangular index.
No takes yet. Share an insight, caveat, or question.
Baumgartner et al. (2023) conducted a cross-sectional in Established atrial fibrillation (n=1,969). Whole blood omega-3 fatty acid levels (total n-3 FAs, EPA, DHA, DPA, and ALA) was evaluated on Prevalence of nonparoxysmal atrial fibrillation (persistent or permanent AF vs paroxysmal AF) at baseline (OR 0.97, 95% CI 0.89-1.05). Total blood omega-3 fatty acid levels were not associated with nonparoxysmal versus paroxysmal atrial fibrillation in multivariate analysis.
Synapse has enriched 10 related papers. Consider them for comparative context: